Clinical Trial Update: Detecting an MCI and Amyloid Digital Neuro Signature(DNS) Using Altoida's Multimodal Digital Biomarkers.

View source ↗

Summary

A completed clinical trial evaluating Altoida's multimodal digital biomarkers for detecting mild cognitive impairment and amyloid-related signatures in Alzheime…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: Altoida | Conditions: Alzheimer Disease, MCI | Status: COMPLETED